Candidiasis of vulva and vagina. Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere
Conditions
Interventions
Intervention 1: The women in intervention group will recipient of 400 mg vaginal Salvia officinalis tablet and clotrimazol placebo once a day for seven day. Intervention 2: The women in intervention
Treatment - Drugs
The women in intervention group will recipient of 400 mg vaginal Salvia officinalis tablet and clotrimazol placebo once a day for seven day
The women in intervention group will recipient of 400 mg vaginal Salvia officinalis tablet and 100 mg vaginal Clotrimazole tablet once a day for seven day
women in control group wiil recipient of 100 mg tablet vaginal clotrimazol and clotrimazol placebo
Sponsors
Vice chancellor for research, Tabriz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
15 Years to 49 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: clinical signs of candidal vaginitis; Positive tests for direct observation; Positive discharge cultures; married; 15-49 years old; Reading and writing literacy herself or a family member; Willingness to participate in the study and Possibility to visit the clinic at the requested time; Having a phone call. Exclusion criteria: pregnant and lactating and Menopause women; use of antibiotics and medications that suppress the immune system (corticosteroids) and the use of vaginal medication in the last two weeks; suffering from autoimmune diseases; chronic disease and hypothyroidism...; Having menstrual bleeding or bleeding between two monthly cycles during a visit; trichomoniasis and Gardnerella positive; use of contraceptive pills and high carbohydrate intake; occurrence of symptoms of drug allergy.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Determine clinical and laboratory results. Timepoint: one and 12 week after treatment. Method of measurement: By signs checklist,wet test,Gram colorin and culture. | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical complaints of patients. Timepoint: One and 12 weeks after starting treatment. Method of measurement: Clinical symptom checklist. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactfatemeh ahangari
Faculty of Nursing & Midwifery, Tabriz University of Medical Sciences
Outcome results
None listed